Skip to search formSkip to main contentSkip to account menu

SRI-5

Known as: SRI 5 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Antineoplastic Agents, AlkylatingAziridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
28 Drivers of the sle responder index (sri-5) endpoint in clinical trials of sle
Background and Aims SRI is a composite endpoint used in many SLE trials. The current investigation sought to identify those SRI… 
2016
2016
EXPLORER : une nouvelle perspective sur d’anciennes données
2015
2015
Targeting BAFF/BLyS in lupus: is the glass half-full or half-empty?
BAFF/BLyS, a pivotal cytokine in B-cell development, survival and proliferation,1 became a trusted target in systemic lupus… 
2015
2015
OP0079 Pharmacodynamic Changes in Gene Expression Observed in Two Phase 3 Trials of Baff Blockade with Tabalumab in SLE
Background RNA gene expression profiling was performed on 1,760 SLE patients randomly selected from Illuminate Trials 1 & 2 which… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)